References
- Schattner A., Malnick S. D. Anicteric hepatitis and uveitis in a worker exposed to trichloroethylene. Postgrad Med J 1990; 66: 730–731
- Bauer M., Rabens S. F. Cutaneous manifestations of trichloroethylene toxicity. Arch Dermatol 1974; 110: 886–890
- Phoon W. H., Chan M. O., Rajan V. S., Tan K. J., Thirumoorthy T., Goh C. L. Stevens-Johnson syndrome associated with occupational exposure to trichloroethylene. Contact Dermatitis 1984; 10: 270–276
- Nakayama H., Kobayashi M., Takahashi M., Ageishi Y., Takano T. Generalized eruption with severe liver dysfunction associated with occupational exposure to trichloroethylene. Contact Dermatitis 1988; 19: 48–51
- Davidson I. W., Beliles R. P. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab Rev 1991; 23: 493–599
- Ray D. C., Drummond G. B. Halothane hepatitis. Br J Anaesth 1991; 67: 84–99
- Christen U., Quinn J., Yeaman S. J., et al. Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid. Eur J Biochem 1994; 223: 1035–1047
- Gut J., Christen U., Huwyler J., Burgin M., Kenna J. G. Molecular mimicry of trifluoroacetylated human liver protein adducts by constitutive proteins and immunochemical evidence for its impairment in halothane hepatitis. Eur J Biochem 1992; 210: 569–576
- Smith G. C., Kenna J. G., Harrison D. J., Tew D., Wolf C. R. Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis. Lancet 1993; 342: 963–964
- Gut J., Christen U., Huwyler J. Mechanisms of halothane toxicity: novel insights. Pharmacol Ther 1993; 58: 133–155
- Cousins M. J., Sharp J. H., Gouriay G. K., Adams J. F., Haynes W. D., Whitehead R. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity. Anaesth Intensive Care 1979; 7: 9–24